Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Maltais (Quebec, Canada). Systemic consequences (cardiovascular, muscular and metabolic aspects) of chronic inactivity in chronic cardio-respiratory diseases including COPD. Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD

Member's Comments

No comment yet.

Related content which might interest you: The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006 Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Complex chronic comorbidities of COPD Source: Eur Respir J 2008; 31: 204-212 Year: 2008 Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases Source: Eur Respir Monogr 2020; 88: 167-183 Year: 2020 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 Nutritional and metabolic modulation in chronic obstructive pulmonary disease management Source: Eur Respir J 2003; 22: 81S-86S Year: 2003 Investigating the fatigue and related factors in patients with chronic obstructive pulmonary disease. Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease Year: 2017 Early peripheral muscle structural and metabolic impairment in chronic obstructive pulmonary disease (COPD) patients cannot be considered as a consequence of sedentarity Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers Year: 2011 Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Is there a strong relationship between COPD and cardiovascular diseases? Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Systemic inflammation in chronic respiratory disease Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=46 Year: 2003 Systemic manifestations and comorbidities of COPD Source: Eur Respir J 2009; 33: 1165-1185 Year: 2009